SCHEMBL22014136

SCHEMBL22014136

CCc1ccc(N)cc1CC(=O)Nc1ccccn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.54
▸ KMT2A Q03164 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ SLC6A2 P23975 1/20 0.50
▸ SLC6A3 Q01959 1/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ ESR1 P03372 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ STAT3 P40763 1/20 0.49
▸ ESR2 Q92731 1/20 0.49
▸ CYP1A2 P05177 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ ALDH1A1 P00352 2/20 0.47
▸ NPC1 O15118 4/20 0.47
▸ RAB9A P51151 4/20 0.47
▸ HDAC3 O15379 2/20 0.46
▸ HDAC4 P56524 2/20 0.46
▸ HDAC1 Q13547 2/20 0.46
▸ HDAC7 Q8WUI4 2/20 0.46
▸ HDAC2 Q92769 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5161662 0.87 GAA (0.56) GAAKMT2AMEN1SLC6A2SLC6A3
SCHEMBL18699858 0.84 CYP1A2 (0.53) GAAKMT2AMEN1SLC6A2SLC6A3
SCHEMBL6490488 0.78 KMT2A (0.74) GAAKMT2AMEN1SLC6A2SLC6A3
SCHEMBL18699685 0.76 GAA (0.49) GAAKMT2AMEN1SLC6A2SLC6A3
SCHEMBL5160350 0.75 GAA (0.55) GAAKMT2AMEN1SLC6A2SLC6A3
SCHEMBL20020504 0.75 GAA (0.51) GAAKMT2AMEN1SLC6A2SLC6A3
SCHEMBL30071250 0.74 GAA (0.76) GAAKMT2AMEN1SLC6A2SLC6A3
SCHEMBL626827 0.74 GAA (0.76) GAAKMT2AMEN1SLC6A2SLC6A3
SCHEMBL20020808 0.73 KMT2A (0.49) GAAKMT2AMEN1SLC6A2SLC6A3
SCHEMBL4709278 0.73 KMT2A (0.58) GAAKMT2AMEN1SLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3708566-A1 NOVEL HETEROCYCLIC COMPOUNDS AND THE USE THEREOF IN MEDICINE AND IN COSMETICS Galderma Research & Development (FR) 2020-09-16 — — EP disclosed
WO-2020099885-A1 HETEROCYCLIC SPIRO-COMPOUNDS AS AM2 RECEPTOR INHIBITORS THE UNIVERSITY OF SHEFFIELD (GB) 2020-05-22 — — WO disclosed
Send feedback